Evaluation of the pediatric-centered integrated care AOK Junior: protocol for a mixed-method study.
Adolescent
Child
Child Health Services
/ organization & administration
Cost-Benefit Analysis
Cross-Sectional Studies
Delivery of Health Care, Integrated
Female
Focus Groups
Germany
Health Services Research
Humans
Male
National Health Programs
/ economics
Primary Health Care
/ organization & administration
Surveys and Questionnaires
Children
Health economic evaluation
Prevention
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
16 Mar 2020
16 Mar 2020
Historique:
received:
18
12
2019
accepted:
09
03
2020
entrez:
18
3
2020
pubmed:
18
3
2020
medline:
28
10
2020
Statut:
epublish
Résumé
The "AOK-Junior" care program of the AOK Nordost (a German statutory health insurance) completes the primary care for children and adolescents (C&A) in the federal states of Berlin, Brandenburg and Mecklenburg-Vorpommern in Germany. The focus of this program is on prevention and early detection of illness on C&A. Furthermore, the aim is to maintain the health of C&A and to prevent, detect and treat illness on time. Elements of the program are not only the integrated care of C&A, but also, for example, weight reduction and additional medical checkups U10, U11 and J2. The evaluation of the complex intervention should provide information about the effectiveness of early disease detection and costs-effectiveness as well as of other parameters like satisfaction. The evaluation is performed on the levels of structural-, process- and results-quality. The cost effectiveness is also assessed by means of a health economic evaluation. In addition to the collection of qualitative and quantitative primary data from participating and non-participating C&A and paediatricians, routine data from a statutory health insurance are used in the evaluation. Furthermore, a cross-sectional design is used to evaluate the structure and process quality. The effectiveness is evaluated in longitudinal section design on the basis of the secondary data. The quantitative surveys include net n = 1096 C&A and n = 340 pediatricians. For the focus groups, a sample of 72 to 96 parents as well as pediatricians will be sought by using the method of theoretical sampling. Around 560 pediatricians and 63,000 C&A currently participate in the AOK Nordost care program. The project provides information to what extent secondary preventive measures can lead to the early detection of diseases and on the associated cost-effectiveness. Furthermore, potentials and barriers of the program implementation are identified. The results of the evaluation study are expected not only to contribute to the further development of the care program, but also to derive recommendations for action. German Clinical Trials Register (DRKS), DRKS-ID: DRKS00015280. Prospectively registered on 18 March 2019.
Sections du résumé
BACKGROUND
BACKGROUND
The "AOK-Junior" care program of the AOK Nordost (a German statutory health insurance) completes the primary care for children and adolescents (C&A) in the federal states of Berlin, Brandenburg and Mecklenburg-Vorpommern in Germany. The focus of this program is on prevention and early detection of illness on C&A. Furthermore, the aim is to maintain the health of C&A and to prevent, detect and treat illness on time. Elements of the program are not only the integrated care of C&A, but also, for example, weight reduction and additional medical checkups U10, U11 and J2. The evaluation of the complex intervention should provide information about the effectiveness of early disease detection and costs-effectiveness as well as of other parameters like satisfaction.
METHODS
METHODS
The evaluation is performed on the levels of structural-, process- and results-quality. The cost effectiveness is also assessed by means of a health economic evaluation. In addition to the collection of qualitative and quantitative primary data from participating and non-participating C&A and paediatricians, routine data from a statutory health insurance are used in the evaluation. Furthermore, a cross-sectional design is used to evaluate the structure and process quality. The effectiveness is evaluated in longitudinal section design on the basis of the secondary data. The quantitative surveys include net n = 1096 C&A and n = 340 pediatricians. For the focus groups, a sample of 72 to 96 parents as well as pediatricians will be sought by using the method of theoretical sampling.
DISCUSSION
CONCLUSIONS
Around 560 pediatricians and 63,000 C&A currently participate in the AOK Nordost care program. The project provides information to what extent secondary preventive measures can lead to the early detection of diseases and on the associated cost-effectiveness. Furthermore, potentials and barriers of the program implementation are identified. The results of the evaluation study are expected not only to contribute to the further development of the care program, but also to derive recommendations for action.
TRIAL REGISTRATION
BACKGROUND
German Clinical Trials Register (DRKS), DRKS-ID: DRKS00015280. Prospectively registered on 18 March 2019.
Identifiants
pubmed: 32178662
doi: 10.1186/s12913-020-05088-7
pii: 10.1186/s12913-020-05088-7
pmc: PMC7077135
doi:
Types de publication
Controlled Clinical Trial
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
217Subventions
Organisme : Federal Joint Committee (G-BA), Innovation Fund
ID : 01VSF17004
Références
Int J Obes Relat Metab Disord. 1998 Aug;22 Suppl 1:S3-5; discussion S6
pubmed: 9758237
Expert Rev Pharmacoecon Outcomes Res. 2005 Jun;5(3):353-64
pubmed: 19807604
Dtsch Arztebl Int. 2010 Jul;107(28-29):495-9
pubmed: 20703333
Z Evid Fortbild Qual Gesundhwes. 2016;110-111:85-92
pubmed: 26875040
BMC Med Res Methodol. 2011 Mar 11;11:26
pubmed: 21396104
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jul;57(7):878-91
pubmed: 24950837
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
Gesundheitswesen. 2005 Jun;67(6):422-31
pubmed: 16001357
Qual Health Res. 2019 Aug;29(10):1483-1496
pubmed: 30628545
Psychiatr Prax. 2012 Nov;39(8):367-8
pubmed: 23138326
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131